Aucubin

Aucubin is an iridoid glycoside found primarily in plantain (Plantago species), eyebright (Euphrasia officinalis), and aucuba (Aucuba japonica) that exerts antioxidant effects through direct free radical scavenging. Its core mechanism involves neutralizing reactive oxygen species including DPPH, superoxide, and hydroxyl radicals, though human clinical evidence remains absent.

Origin & History

Aucubin is an iridoid glycoside compound extracted primarily from Eucommia ulmoides (hardy rubber tree) and plantain species. The compound is isolated through various extraction methods including maceration, ultrasound-assisted extraction, and deep eutectic solvent extraction, with optimal yields of 156.4-156.8 mg/g achieved using deep eutectic solvents under controlled conditions.

Historical & Cultural Context

No information regarding traditional use, historical applications, or cultural significance of aucubin was provided in the available research. The current literature focuses exclusively on modern extraction techniques without historical context.

Health Benefits

• Antioxidant activity demonstrated in laboratory studies with strong free radical scavenging capabilities for four types of free radicals including DPPH (preliminary evidence only)
• No human clinical benefits documented in the provided research
• No therapeutic effects verified through controlled trials
• No meta-analyses available to confirm health claims
• Current evidence limited to in vitro antioxidant properties only

How It Works

Aucubin operates as a free radical scavenger by donating hydrogen atoms to neutralize reactive oxygen species, including DPPH radicals, superoxide anions, hydroxyl radicals, and ABTS radical cations, as demonstrated in in vitro assays. After oral ingestion, intestinal microbiota hydrolyze aucubin's glucoside bond via beta-glucosidase enzymes, releasing the active aglycone aucubigenin, which may modulate NF-κB signaling pathways to reduce downstream pro-inflammatory cytokine expression. Animal studies additionally suggest interaction with Nrf2-ARE pathway activation, potentially upregulating endogenous antioxidant enzymes such as superoxide dismutase and catalase.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses were found in the provided research. The available literature focuses solely on extraction optimization and laboratory-based antioxidant assessments rather than clinical outcomes in human subjects.

Clinical Summary

Current evidence for aucubin is limited entirely to in vitro cell culture studies and rodent animal models, with zero published randomized controlled trials in human subjects. Laboratory studies have quantified strong DPPH radical scavenging activity with IC50 values in the micromolar range, comparable to established reference antioxidants in controlled assays. Rodent studies have explored hepatoprotective and neuroprotective effects at doses typically ranging from 10–100 mg/kg body weight, but these findings cannot be directly extrapolated to human therapeutic dosing. No human clinical trials have verified efficacy, safety thresholds, or effective dosing ranges, making all purported health benefits preliminary and unconfirmed.

Nutritional Profile

Aucubin is an iridoid glycoside (molecular formula C15H22O9, molecular weight 346.33 g/mol) and is not a macronutrient, micronutrient, or dietary staple. It contains no caloric value, protein, fat, or fiber content as a pure isolated compound. As a bioactive phytochemical, it is found in trace-to-moderate concentrations in plants such as Plantago major (plantain leaves: approximately 0.1–1.5% dry weight), Eucommia ulmoides bark (0.06–1.0% dry weight), and Aucuba japonica. The compound consists structurally of a bicyclic iridoid core linked to a glucose moiety via a beta-glycosidic bond. Bioavailability data in humans is extremely limited; in animal models, the glycosidic bond is subject to hydrolysis by intestinal microbiota, releasing the aglycone form, which may affect absorption kinetics. No established dietary reference intake exists. Antioxidant capacity has been quantified in vitro with demonstrated free radical scavenging activity against DPPH, hydroxyl radicals, superoxide anions, and ABTS radicals, though specific IC50 values vary by study and source material. No vitamin, mineral, or fiber content is inherent to this isolated compound.

Preparation & Dosage

No clinically studied dosage ranges are available in the current research. The literature only provides extraction yield data (156.4-156.8 mg/g from plant material) rather than therapeutic dosing protocols for human use. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient data for synergistic recommendations

Safety & Interactions

No formal human safety studies have been conducted on isolated aucubin supplements, meaning a verified safe dosage range, tolerable upper intake level, or comprehensive adverse effect profile has not been established. Because aucubin is metabolized by gut microbiota, individuals with dysbiosis or those taking broad-spectrum antibiotics may experience altered bioavailability and unpredictable pharmacokinetics. Theoretical interactions exist with anticoagulant medications such as warfarin given that aucubin-containing plants like Plantago species have demonstrated mild platelet-modulating activity in preclinical models. Pregnant and breastfeeding women should avoid isolated aucubin supplements due to a complete absence of reproductive safety data.